Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Retatrutide is an investigational triple incretin receptor agonist not yet approved by the MHRA or EMA for use in the UK, meaning its use outside regulated clinical trials is unlawful
Yes, PlexusDx compounded tirzepatide is made by licensed 503A compounding pharmacies and meets rigorous quality standards
Compounded tirzepatide is prepared by a state-licensed compounding pharmacy under physician supervision
The foam traps air and makes it difficult to achieve complete dissolution
US$ 22.69
US$ 20.19
US$ 28.31
US$ 29.76
